Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A First-in-human Phase 1/2 Study of FGF401 and Combination of FGF401 with Spartalizumab in Patients with Hepatocellular Carcinoma or Biomarker-Selected Solid Tumors

Chan Stephen L.,Schuler Martin,Kang Yoon-Koo,Yen Chia-Jui,Edeline Julien,Choo Su Pin,Lin Chia-Chi,Okusaka Takuji,Weiss Karl-Heinz,Macarulla Teresa,Cattan Stéphane,Blanc Jean-Frederic,Lee Kyung-Hun,Maur Michela,Pant Shubham,Kudo Masatoshi,Assenat Eric,Zhu Andrew X.,Yau Thomas,Lim Ho Yeong,Bruix Jordi,Geier Andreas,Guillén-Ponce Carmen,Fasolo Angelica,Finn Richard S.,Fan Jia,Vogel Arndt,Qin Shukui,Riester Markus, Katsanou Vasiliki,Chaudhari Monica,Kakizume Tomoyuki,Gu Yi,Porta Diana Graus,Myers Andrea,Delord Jean-Pierre

Journal of Experimental & Clinical Cancer Research（2022）

Cited 13|Views35
No score
Key words
Hepatocellular carcinoma,FGFR4,PD-1,PD-L1,Immune checkpoint inhibitors,Phase 1,KLB,FGF19
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined